β-Arrestin Activity: Unlike traditional opioids, mitragynine does not recruit β-arrestin 2 at the mu-opioid receptor, which is significant because β-arrestin 2 recruitment is linked to several adverse effects of opioids, including respiratory depression, constipation, and tolerance [15]. Here, OPRM1 is linked to Respiratory insufficiency due to muscle weakness.